Targeted therapy in thyroid cancer: state of the art
L Valerio, L Pieruzzi, C Giani, L Agate, V Bottici… - Clinical oncology, 2017 - Elsevier
Thyroid cancer typically has a good outcome following standard treatments, which include
surgery, radioactive iodine ablation for differentiated tumours and treatment with thyrotropine …
surgery, radioactive iodine ablation for differentiated tumours and treatment with thyrotropine …
Advances in ultra-high-resolution mass spectrometry for pharmaceutical analysis
E Deschamps, V Calabrese, I Schmitz, M Hubert-Roux… - Molecules, 2023 - mdpi.com
Pharmaceutical analysis refers to an area of analytical chemistry that deals with active
compounds either by themselves (drug substance) or when formulated with excipients (drug …
compounds either by themselves (drug substance) or when formulated with excipients (drug …
[PDF][PDF] Technical report: pricing of cancer medicines and its impacts: a comprehensive technical report for the World Health Assembly Resolution 70.12: operative …
World Health Organization - 2018 - apps.who.int
In 2017, the Seventieth World Health Assembly adopted resolution WHA70. 12 on Cancer
prevention and control in the context of an integrated approach (Appendix A). Operative …
prevention and control in the context of an integrated approach (Appendix A). Operative …
Policies to encourage the use of biosimilars in European countries and their potential impact on pharmaceutical expenditure
S Vogler, P Schneider, M Zuba, R Busse… - Frontiers in …, 2021 - frontiersin.org
Introduction: Biosimilar medicines are considered promising alternatives to new biologicals
with high price tags. The extent of savings resulting from biosimilar use depends on their …
with high price tags. The extent of savings resulting from biosimilar use depends on their …
Reboot biomedical R&D in the global public interest
S Swaminathan, B Pécoul, H Abdullah, C Christou… - Nature, 2022 - nature.com
Reboot biomedical R&D in the global public interest Skip to main content Thank you for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best …
nature.com. You are using a browser version with limited support for CSS. To obtain the best …
Comparing generic drug markets in Europe and the United States: prices, volumes, and spending
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …
drug markets in Europe and the United States. Regulators should make it easier for generic …
Gene therapies development: slow progress and promising prospect
E Hanna, C Rémuzat, P Auquier… - Journal of market access …, 2017 - Taylor & Francis
Background: In 1989, the concept of human gene therapies has emerged with the first
approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as …
approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as …
Implementation of value-based pricing for medicines
Value-based pricing (VBP) is well established in markets for common goods and services,
but wide consensus on VBP for pharmaceuticals is lacking. In principle, VBP implies that …
but wide consensus on VBP for pharmaceuticals is lacking. In principle, VBP implies that …
[책][B] Ensuring access to medicines: How to redesign pricing, reimbursement and procurement?
S Vogler, V Paris, D Panteli - 2018 - researchgate.net
In recent years policy-makers in European countries have been increasingly concerned
about developments in the pharmaceutical sector that have been challenging the …
about developments in the pharmaceutical sector that have been challenging the …
Comparison of prices and affordability of cancer medicines in 16 countries in Europe and Latin America
D Moye-Holz, S Vogler - Applied Health Economics and Health Policy, 2022 - Springer
Background There are concerns that high prices of cancer medicines may limit patient
access. Since information on prices for cancer medicines and their impact on affordability is …
access. Since information on prices for cancer medicines and their impact on affordability is …